Rankings
▼
Calendar
ELAN (Elanco Animal Health Incorporated) Stock Financials & Earnings | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
Mkt Cap
$12B
Healthcare
·
Drug Manufacturers - Specialty & Generic
·
🇺🇸 United States
·
NYSE
Revenue (TTM)
$4.7B
Net Income (TTM)
-$232M
EPS (TTM)
-$0.47
Free Cash Flow (TTM)
$284M
Gross Margin
46.4%
Op. Margin
5.3%
Net Margin
-4.9%
FCF Margin
6.0%
P/S Ratio (TTM)
2.5x
P/E Ratio (TTM)
—
YoY Rev Growth
+6.2%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$1.3B
$629M
$221M
Q2 23
$1.1B
$487M
$53M
Q3 23
$1.1B
$441M
$42M
Q4 23
$1.0B
$381M
$10M
Q1 24
$1.2B
$557M
$133M
Q2 24
$1.2B
$558M
$115M
Q3 24
$1.0B
$405M
-$5M
Q4 24
$1.0B
$389M
$8M
Q1 25
$1.2B
$556M
$121M
Q2 25
$1.2B
$577M
$85M
Q3 25
$1.1B
$607M
$27M
Q4 25
$1.1B
$450M
$19M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
2.7x
—
Q2 23
2.8x
—
Q3 23
2.7x
—
Q4 23
2.7x
—
Q1 24
2.7x
—
Q2 24
2.7x
—
Q3 24
2.7x
58.4x
Q4 24
2.7x
35.4x
Q1 25
2.7x
32.1x
Q2 25
2.7x
27.6x
Q3 25
2.6x
332.7x
Q4 25
2.5x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$145M
-$183M
Q2 23
$61M
$19M
Q3 23
$198M
$165M
Q4 23
$157M
$116M
Q1 24
$2M
-$22M
Q2 24
$200M
$166M
Q3 24
$162M
$120M
Q4 24
$177M
$124M
Q1 25
-$4M
-$69M
Q2 25
$237M
$180M
Q3 25
$219M
$127M
Q4 25
$108M
$46M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$38M
Q2 23
$42M
Q3 23
$33M
Q4 23
$41M
Q1 24
$24M
Q2 24
$34M
Q3 24
$42M
Q4 24
$53M
Q1 25
$65M
Q2 25
$57M
Q3 25
$92M
Q4 25
$62M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+2.5%
-1.3%
Q2 23
-10.0%
-3.6%
Q3 23
+4.1%
+5.1%
Q4 23
+4.8%
+6.7%
Q1 24
-4.1%
+3.5%
Q2 24
+12.0%
+6.5%
Q3 24
-3.6%
+0.9%
Q4 24
-1.4%
-1.3%
Q1 25
-1.0%
+0.0%
Q2 25
+4.8%
+8.1%
Q3 25
+10.4%
+7.2%
Q4 25
+12.2%
+11.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$12M
1.0%
Q2 23
$9M
0.9%
Q3 23
$10M
0.9%
Q4 23
$15M
1.4%
Q1 24
$11M
0.9%
Q2 24
$14M
1.2%
Q3 24
$15M
1.5%
Q4 24
$15M
1.5%
Q1 25
$15M
1.3%
Q2 25
$20M
1.6%
Q3 25
$17M
1.5%
Q4 25
$16M
1.4%
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$81M
—
$327M
Q2 23
$81M
—
$353M
Q3 23
$86M
—
$313M
Q4 23
$79M
—
$292M
Q1 24
$87M
—
$337M
Q2 24
$89M
—
$354M
Q3 24
$87M
—
$323M
Q4 24
$81M
—
$300M
Q1 25
$94M
—
$341M
Q2 25
$92M
—
$400M
Q3 25
$89M
$351M
—
Q4 25
$93M
—
$338M
marketcaparena.com
Revenue Segments
Quarter
marketcaparena.com
Revenue by Geography
Non-US
United States
Quarter
Non-US
United States
Q1 23
$714M
$543M
Q2 23
$557M
$500M
Q3 23
$589M
$479M
Q4 23
$574M
$461M
Q1 24
$674M
$531M
Q2 24
$641M
$543M
Q3 24
$543M
$487M
Q4 24
$545M
$475M
Q1 25
$639M
$554M
Q2 25
$648M
$593M
Q3 25
$590M
$547M
Q4 25
$604M
$540M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$318M
$0
$318M
Q2 23
$367M
$0
$367M
Q3 23
$369M
$0
$369M
Q4 23
$352M
$0
$352M
Q1 24
$345M
$0
$345M
Q2 24
$416M
$0
$416M
Q3 24
$490M
$0
$490M
Q4 24
$468M
$0
$468M
Q1 25
$487M
$0
$487M
Q2 25
$539M
$0
$539M
Q3 25
$505M
$0
$505M
Q4 25
$545M
$0
$545M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
493M
+0.9%
Q2 23
493M
-0.0%
Q3 23
493M
+0.0%
Q4 23
493M
+0.0%
Q1 24
496M
+0.6%
Q2 24
494M
-0.4%
Q3 24
498M
+0.7%
Q4 24
494M
-0.7%
Q1 25
499M
+1.0%
Q2 25
500M
+0.2%
Q3 25
497M
-0.7%
Q4 25
497M
+0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 15
—
—
FY 16
—
—
FY 17
—
—
FY 18
$549K
6K
FY 19
$533K
6K
FY 20
$348K
9K
FY 21
$529K
9K
FY 22
$490K
9K
FY 23
$475K
9K
FY 24
$493K
9K
FY 25
$502K
9K
marketcaparena.com